In addition, for the first time, LASS2 overexpression was found to further inhibit cancer cell invasion and migration by regulating the ferroptosis signalling pathway in thyroid, breast, and hepatocellular cancer cells, possibly through direct interactions between LASS2 and TFRC. Here, CERS2 is linked to hepatocellular carcinoma.